Emergency cerclage using double-level versus single-level suture in the management of cervical insufficiency (Cervical Occlusion double-level Stitch Application, COSA): study protocol for a multicentre, non-blinded, randomised controlled trial

被引:1
|
作者
Kaczynska, Katarzyna Kosinska [1 ]
Rebizant, Beata [1 ]
Bednarek, Katarzyna [1 ]
Dabrowski, Filip Andrzej [1 ]
Kajdy, Anna [2 ]
Muzyka-Placzynska, Katarzyna [2 ]
Filipecka-Tyczka, Dagmara [2 ]
Uzar, Piotr [3 ]
Kwiatkowski, Sebastian [4 ]
Torbe, Andrzej [3 ]
Grzesiak, Mariusz [5 ]
Kaczmarek, Piotr [5 ]
Zyla, Monika [5 ]
Brawura-Biskupski-Samaha, Robert [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Obstet Perinatol & Neonatol, Warsaw, Poland
[2] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 1, Warsaw, Poland
[3] Pomeranian Med Univ, Dept Obstet & Gynecol, Szczecin, Poland
[4] Pomorski Uniwersytet Med Szczecinie, Dept Obstet & Gynecol, Szczecin, Poland
[5] Polish Mothers Mem Hosp Res Inst, Dept Perinatol Obstet & Gynecol, Lodz, Poland
来源
BMJ OPEN | 2023年 / 13卷 / 06期
关键词
Maternal medicine; NEONATOLOGY; Neonatal intensive & critical care; BED REST;
D O I
10.1136/bmjopen-2023-071564
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Cervical insufficiency accounts for 15% of recurrent pregnancy losses between 16 and 28 weeks of gestation. The aim of the study is to verify the effectiveness of emergency double-level cerclage with vaginal progesterone in cervical insufficiency treatment in terms of the prevention of preterm delivery before 34 weeks of gestation. Methods and analysis This trial is a multicentre, non-blinded, randomised study with 1:1 allocation ratio. The study is conducted at tertiary perinatal care departments in Poland. It will include patients with cervical insufficiency with the fetal membranes visible in the open cervical canal or protruding into the vagina between 16+0and 23+6 weeks of pregnancy. They will be randomised into two arms: emergency single-level cerclage with vaginal progesterone or double-level cerclage with vaginal progesterone. All will be administered antibiotics and indomethacin. The primary outcome is the rate of deliveries below 34+0 weeks of gestation, while secondary outcomes include gestational age at delivery, neonatal outcomes, maternal outcomes according to the Core Outcome Set for Evaluation of Interventions to Prevent Preterm Birth and cerclage procedure complications. The planned number of participants according to the power analysis is 78. Ethics and dissemination The study protocol was written in accordance with the Standard Protocol Items: Recommendations for Interventional Trials statement. It was created according to the requirements of the Declaration of Helsinki for Medical Research involving Human Subject. Ethical approval was obtained from the Ethics Committee of the Centre of Postgraduate Medical Education (no. 1/2022). The study protocol was approved and published by ClinicalTrials.gov (posted on 24 February 2022). All participants gave a written informed consent. After completion of the study its results will be published in a peer-reviewed English language journal.
引用
收藏
页数:7
相关论文
共 3 条
  • [1] Transforaminal versus posterior lumbar interbody fusion for symptomatic single-level spondylolisthesis (LIFT): a multicentre controlled, patient blinded, randomised non-inferiority trial
    Caelers, Inge J. M. H.
    Droeghaag, Ruud
    de Kunder, Suzanne L.
    Most, Jasper
    Rijkers, Kim
    Bartels, Ronald H. M. A.
    Kuijlen, Jos M. A.
    Hulsbosch, Mark H. H. M.
    van Hemert, Wouter L. W.
    de Bie, Rob A.
    van Santbrink, Henk
    LANCET REGIONAL HEALTH-EUROPE, 2024, 43
  • [2] The Norwegian Cervical Arthroplasty Trial (NORCAT): 2-year clinical outcome after single-level cervical arthroplasty versus fusion—a prospective, single-blinded, randomized, controlled multicenter study
    Jarle Sundseth
    Oddrun Anita Fredriksli
    Frode Kolstad
    Lars Gunnar Johnsen
    Are Hugo Pripp
    Hege Andresen
    Erling Myrseth
    Kay Müller
    Øystein P. Nygaard
    John-Anker Zwart
    European Spine Journal, 2017, 26 : 1225 - 1235
  • [3] The Norwegian Cervical Arthroplasty Trial (NORCAT): 2-year clinical outcome after single-level cervical arthroplasty versus fusion-a prospective, single-blinded, randomized, controlled multicenter study
    Sundseth, Jarle
    Fredriksli, Oddrun Anita
    Kolstad, Frode
    Johnsen, Lars Gunnar
    Pripp, Are Hugo
    Andresen, Hege
    Myrseth, Erling
    Mueller, Kay
    Nygaard, Oystein P.
    Zwart, John-Anker
    EUROPEAN SPINE JOURNAL, 2017, 26 (04) : 1225 - 1235